EVI1 Drives Leukemogenesis through Aberrant ERG Activation

Investigators developed experimentally tractable human and murine disease models, investigated the transcriptional consequences of EVI1 withdrawal in vitro and in vivo, and performed the first genome-wide CRISPR screens in EVI1-dependent AML.